newsfilter
← Latest News
GlobeNewswire·

Ligand to Participate in November Investor Conferences

JUPITER, Fla., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that its senior management team will participate in the following upcoming investor conferences: UBS